XML 32 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Unaudited Condensed Consolidated Statements of Cash Flows (Q1) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net income $ 440,895 $ 3,709,017
Adjustments to reconcile net income to net cash used in operating activities:    
Interest income on cash and marketable securities held in Trust Account (1,845,005) (72,684)
Unrealized loss on marketable securities held in Trust Account 3,165
Change in fair value of warrant liabilities 574,137 (3,877,929)
Deferred tax benefit (35,597)
Prepaid expenses and other current assets 25,860 32,167
Accrued offering costs and expenses 14,529 (19,310)
Income tax payable (159,591)
Due to related party 15,000 (1,613)
Net cash used in operating activities (966,607) (230,352)
Payment of extension fee into Trust Account (48,707)
Cash withdrawn from Trust Account in connection with redemption 184,845,836
Reimbursement of franchise and income taxes from Trust Account 877,438
Net cash provided by (used in) investing activities 185,674,567
Cash flows from financing activities:    
Redemption of common stock (184,845,836)
Net cash provided by (used in) financing activities (184,845,836)
Net change in cash (137,876) (230,352)
Cash, beginning of the period 193,486 741,228
Cash, end of the period 55,610 $ 510,876
Supplemental disclosure of cash flow information:    
Income taxes paid 597,437  
Excise tax expense related to stock redemptions 1,848,455  
Accretion of common stock to redemption value $ 1,279,617